CpG DNA as a vaccine adjuvant
Top Cited Papers
- 1 April 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 10 (4) , 499-511
- https://doi.org/10.1586/erv.10.174
Abstract
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) to mount an inna...Keywords
This publication has 143 references indexed in Scilit:
- Short- and long-term changes in gene expression mediated by the activation of TLR9Molecular Immunology, 2010
- CpG‐enhanced CD8+ T‐cell responses to peptide immunization are severely inhibited by B cellsEuropean Journal of Immunology, 2009
- The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in MaliVaccine, 2009
- A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adultsVaccine, 2009
- TLR9 as a key receptor for the recognition of DNA☆Advanced Drug Delivery Reviews, 2008
- Dendritic cells and innate defense against tumor cellsCytokine & Growth Factor Reviews, 2007
- Systemic but not mucosal immunity induced by AVA prevents inhalational anthraxMicrobes and Infection, 2007
- Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesVaccine, 2007
- MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer modelVaccine, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006